Aarti Pharmalabs Ltd share price logo

Aarti Pharmalabs Ltd (AARTIPHARM)


Get free price alerts. Set up your Free investment account to get Live Prices.
Q3 '23 Results


  • Day's Low

    Day's High

  • 52 Week's Low

    52 Week's High

1 Month Return+ 1.64 %
3 Month Return+ 37.18 %
1 Year Return+ 83.15 %
Previous Close₹616.85
Upper Circuit-
Lower Circuit-
Market Cap₹5,590.27Cr

Key Statistics

P/E Ratio25.77
PEG Ratio9.95
Market Cap₹5,590.27 Cr
P/B Ratio1.73

Mutual Fund Holdings

Funds HoldingsPrev. 2M
Quant Small Cap Fund Growth Option Direct PlanQuant Small Cap Fund Growth Option Direct Plan0.28%
Aditya Birla Sun Life Flexi Cap Fund Direct Plan GrowthAditya Birla Sun Life Flexi Cap Fund Direct Plan Growth0.24%
Quant Flexi Cap Fund Growth Option Direct PlanQuant Flexi Cap Fund Growth Option Direct Plan0.65%
HDFC Multi Cap Fund Direct GrowthHDFC Multi Cap Fund Direct Growth0.17%
Quant Business Cycle Fund Direct GrowthQuant Business Cycle Fund Direct Growth1.51%

Company Information

Smart Building technology is revolutionizing facility management and dramatically improving the quality of life for occupants. Through their digital infrastructure, smart buildings enable building owners, operators, and building users to have greater control over their workspaces, including access control, energy optimization, and real-time analytics. Smart buildings are estimated to save anywhere from 10 to 50% on energy costs. They also have the potential to reduce operational costs, improve safety, and enhance occupant experiences. Smart building components are the backbone of the technology, allowing for monitoring and remote control of the building’s conditions. These components range from occupancy sensors and advanced HVAC systems to AI-based security cameras and energy-efficient lighting systems. Perhaps most significantly, these components come together in an integrated network, making the building a more efficient and healthy environment. Smart Building technology ensures a safe and productive work environment and provides the necessary data to make informed decisions about the building's future.

Share Price: ₹613.35 per share as on 11 Jul, 2024 04:01 PM
Market Capitalisation: ₹5,590.27Cr as of today
Revenue: ₹505.77Cr as on March 2024 (Q1 24)
Net Profit: ₹65.25Cr as on March 2024 (Q1 24)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
OrganisationAarti Pharmalabs Ltd
E-voting on sharesClick here to vote

Key events for Aarti Pharmalabs Ltd

  • Aarti Pharmalabs Ltd Gains as Quant Mutual Fund Buys Shares - 23 May, 2024

    Chemical manufacturer Aarti Pharmalabs saw a 2% increase in share prices after Quant Mutual Fund bought 10.51 lakh equity shares in an NSE bulk deal. The company reported a revenue increase of 4.3% and net profit increase of 51% from Q4FY23 to Q4FY24. APL is the largest Indian manufacturer of Xanthine Derivatives, with a global market share of 15-20%. It operates two dedicated plants with a combined capacity of about 5,000 MTPA for producing Xanthine Derivatives.

  • Quant Mutual Fund Buys 1.1% Stake in Aarti Pharmalabs - 22 May, 2024

    Quant Mutual Fund has acquired a 1.1% stake in Aarti Pharmalabs Limited through a bulk deal, while Baron Emerging Markets Fund sold a 0.95% stake. The former bought around 10 lakh shares at an average price of Rs 575.83 per share, and the latter sold around 8.6 lakh shares at an average price of Rs 573 per share.

  • Aarti Pharmalabs Hits 52-Week High Amidst Increased Activity by High-Frequency Trading Firms - 15 May, 2024

    Aarti Pharmalabs touched a 52-week high on May 14, with increased activity from high-frequency trading firms in small, illiquid stocks. These volumes often attract retail investors.

  • Aarti Pharmalabs Reports Strong Q4 Results - 14 May, 2024

    Aarti Pharmalabs reported a 52.2% YoY increase in Q4 net profit at Rs 65.25 crore, with total income up by 4.5% to Rs 507.8 crore. The stock rallied up to 8.6% following the announcement. Additionally, the board has recommended a final dividend of ₹1 per equity share of ₹5 each (20%) for the financial year ended March 31, 2024.

Insights on Aarti Pharmalabs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.


    Price Rise


    In the last 3 months, AARTIPHARM stock has moved up by 37.2%


    MF Holding Up


    Mutual Funds have increased holdings from 2.05% to 2.72% in Mar 2024 quarter


    Revenue Rich


    Revenue is up for the last 3 quarters, 440.78 Cr → 507.8 Cr (in ₹), with an average increase of 6.7% per quarter


    Profit Spike


    Netprofit is up for the last 5 quarters, 42.87 Cr → 65.25 Cr (in ₹), with an average increase of 9.8% per quarter


    FII Holding Up


    Foreign Institutions have increased holdings from 8.16% to 8.33% in Mar 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged


    Promoters holdings remained unchanged at 46.46% of holdings in Mar 2024 quarter


    Retail Holding Down


    Retail Investor have decreased holdings from 35.46% to 35.23% in Mar 2024 quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Net Income
Net Profit Margin
2023Y/Y Change
Net Income
Net Profit Margin
Value in ₹ crore
2023Y/Y Change
Total Assets
Total Liabilities
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
Foreign Institutions
Mutual Funds
Retail Investors

Key Indicators

Aarti Pharmalabs Ltd Valuation

Aarti Pharmalabs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (11.23x)

February 2, 2023

Today (25.77x)

July 10, 2024

Industry (62.76x)

July 10, 2024

Highest (27.04x)

July 2, 2024


Earnings and Dividends

  • Aarti Pharmalabs Ltd Earnings Results

    Aarti Pharmalabs Ltd’s net profit jumped 52.2% since last year same period to ₹65.25Cr in the Q4 2023-2024. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated 23.67% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Aarti Pharmalabs Ltd Dividends February,2024

    In the quarter ending December 2023, Aarti Pharmalabs Ltd has declared dividend of ₹2 - translating a dividend yield of 0.32%.

    Read More about Dividends

Technicals Summary





Aarti Pharmalabs Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Aarti Pharmalabs Ltd shares.

Aarti Pharmalabs Ltd (AARTIPHARM) share price today is ₹613.35

Aarti Pharmalabs Ltd is listed on NSE

Aarti Pharmalabs Ltd is listed on BSE

  • Today’s highest price of Aarti Pharmalabs Ltd is ₹625.05.
  • Today’s lowest price of Aarti Pharmalabs Ltd is ₹607.6.

PE Ratio of Aarti Pharmalabs Ltd is 25.77

PE ratio = Aarti Pharmalabs Ltd Market price per share / Aarti Pharmalabs Ltd Earnings per share

Today’s traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 1.11L.

Today’s market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹5590.27Cr.

Aarti Pharmalabs Ltd(AARTIPHARMPrice
52 Week High
52 Week Low

Aarti Pharmalabs Ltd(AARTIPHARM) share price is ₹613.35. It is down -7.46% from its 52 Week High price of ₹662.8

Aarti Pharmalabs Ltd(AARTIPHARM) share price is ₹613.35. It is up 91.49% from its 52 Week Low price of ₹320.3

Aarti Pharmalabs Ltd(AARTIPHARMReturns
1 Day Returns
1 Month Returns
3 Month Returns
1 Year Returns